A self-expanding coronary stem was implanted in 17 patients to treat acute occlusion of the right coronary artery after percutaneous transluminal angioplasty . There were 2 women and 15 men, with a mean age of 59 ± S years . All patients underwent at least one follow-up anglographic examination 4 to 6 months after implantation and six patients had additional follow-up angiographyDuring a mean follow-up interval of 32 ± 10 months no patient died or had a myocardial infarction . Restenosis within the stem did not occur . Two patients had a new steussis adjacent to the Despite several major technical improvements, acute occlusion after coronary balloon angioplasty continues to occur in approximately 5% of patients (1-3) . It has been proposed (4,51 that treatment of these patients with coronary sterling would avoid emergency surgery or myocardial infarction . However, recent reports (6,7) have shown that stent occlusion and restenosis within the stout remain important limitations to this treatment. One previous study (4) demonstrated the value of long-term follow-up of patients treated with a stent for acute occlusion after coronary angioplasty . Among our patients treated with a stent for restenosis and acute occlusion, we noted (6) that the great majority of complications occurred in patients whose stent was placed in the left anterior descending coronary artery. Therefore, in this study we assessed the outcome of scent implantatiac in the right coronary artery of patients with acute occlusion after coronary angioplasty .
A self-expanding coronary stem was implanted in 17 patients to treat acute occlusion of the right coronary artery after percutaneous transluminal angioplasty . There were 2 women and 15 men, with a mean age of 59 ± S years . All patients underwent at least one follow-up anglographic examination 4 to 6 months after implantation and six patients had additional follow-up angiographyDuring a mean follow-up interval of 32 ± 10 months no patient died or had a myocardial infarction . Restenosis within the stem did not occur . Two patients had a new steussis adjacent to the Despite several major technical improvements, acute occlusion after coronary balloon angioplasty continues to occur in approximately 5% of patients (1) (2) (3) . It has been proposed (4,51 that treatment of these patients with coronary sterling would avoid emergency surgery or myocardial infarction . However, recent reports (6,7) have shown that stent occlusion and restenosis within the stout remain important limitations to this treatment. One previous study (4) demonstrated the value of long-term follow-up of patients treated with a stent for acute occlusion after coronary angioplasty . Among our patients treated with a stent for restenosis and acute occlusion, we noted (6) that the great majority of complications occurred in patients whose stent was placed in the left anterior descending coronary artery. Therefore, in this study we assessed the outcome of scent implantatiac in the right coronary artery of patients with acute occlusion after coronary angioplasty .
Methods
Study patients. Seventeen patients (15 men and 2 women) with a mean age of 59 ± 8 years underwent balioor . angioplasty of the right coronary artery for angina pectoris (New stent. Stent occlusion was found on follow-up angiography in one patient who had not been treated with an antiptatelet agent . The mean intratuminal diameter was 2 .77 _ 0.5 mm after implantation and 2,67 x 0.5 mm on follow-up angiography .
it is concluded that coronary stealing is effective in treating right coronary artery occlusion after balloon angioplasty. Immediate and tong-term outcome suggest that the right coronary artery may be a particularly favorable site for stent implantation .
(J Am Oil Cordial 1992;19:1593-6)
York Heart Association functional classes 11 to IV) . No patient had had previous coronary angioplasty and 14 patients had single-vessel disease of the right coronary artery . The mean ejection fraction was 0 .68 ± 0.10. The stenosis was located in the mid or distal part of the artery . Ostial lesions were not considered for stem implantation . After conventional coronary angioplasty, all 17 patients had acute occlusion of the artery, with a distal flow grade 0 to I according to the Thrombolysis in Myocardial Infarction (TIMI) classification. Because all patients were candidates for emergency coronary surgery, stent implantation was attempted . Coronary angioplasty and steal implantation . The study protocol was approved by the Ethical Committee of our institution. The day before the procedure, the patients provided informed, written consent to have a stent implanted if acute occlusion occurred during coronary angioplasty . Before angioplasty, patients received 500 mg of aspirin, 10 mg of nifedipine and 15,000 U of heparin. The right femoral approach was used in all patients . An 8F introducer was placed in the artery and an Amplatz or Judkins guiding catheter was used for angioplasty and stem implantation . Angioplasty was performed with an over the wire system . After opaeifcation of the right coronary artery, a 0 .014-in . (0 .036-cm) soft type wire was advanced through the lesion and angioplasty was performed with an Advanced Catheter System or Scimed balloon. Several inflations of 60-to 120-s duration were applied . Stent implantation was performed only if the occlusion persisted after five consecutive inflations .
COY FT AL . SELF-EXPANDING CORONARY STENT
The technique of scent implantation has been described extensively (8) . Briefly, an exchange wire was used to withdraw the angioplasty balloon and an intracoronary infusion of urokinase (100 .000 U) was performed through the guiding catheter. The stent (Wallstent) was advanced through the occlusion and expanded . After implantation of !he stent, a final angioplasty within the stem was performed by using the same balloon used for the initial angioplasty . Administration of acenocoumarot (variable dose, depending on the international-normalized ratio), sulfinpyrazone (600 mglday), aspirin (100 mg/day) and dipyridamole (150 to 300 mglday) was started on the day of implantation . The target anticoagulation level was an international-normalized ratio of >2 .5.
Follow-up . Control angiography was performed in all patients 4 to 6 months after stent implantation . Additional angiograms were obtained when clinically needed in six patients . Quantitative analysis of the intraluminal diameter of the vessel was performed after implantation and at follow-up angiography . Rstenosis was defined as >50% reduction in diameterjudged by visual estimation . Myocardial infarction was defined as an increase in creating kinase (CK) >290 IUlliter (normal value in our hospital) .
Statistical anolysic. All results are presented as mean values ± SD . For statistical anaysis, a Student t test was used and a p value < 0 .05 was considered statistically significant .
Results
Stent implantation . The stem was deployed successfully in all patients. The diameter of Gne stem was 3 mm in two patients, 3 .5 mm in four, 4 mm in eight, 4 .5 mm in one and 5 mm in two . In one patient (treated for masweytosis), acute occlusion occurred after the implantation and the vessel was recanalized ; however, the distal flow remained poor because of peripheral clot emhoitzation . This patient was not treated with an antiplatelet agent before angioplasty . The same patient underwent a follow-up angiogram 24 h after stem implantation and the stent was patent. There was no inhospital death. All patients left the hospital 2 to 7 days after stem implantation. One patient required surgical repair of the femoral artery . After stem implantation, a Q wave myocardial infarction was documented in one patient (5%) and a note-Q wave infarction in four patients (23%) . Only the patient with a Q wave infarction had a change in left ventricular function, with mild inferior hypokinesia . The mean CK value was 357 -_ 280 iU and CK NIB isoenzyme value 38 ± 23 IU .
Follow-up. During the follow-up period, all patients onderwent at least one follow-up angiographic study at our institution 6.1 m I months after scent implantation . Six patients had additional coronary arteriography 35 ± II months after implantation . After a mean clinical follow-up period of 32 ± 10 months, two patients (11%) had recurrence of angina pectoris and right coronary artery stenosis adja-JACC Vol . 19, No. 7 June 1992.1593-6 cent to the stent was documented in both . One of these two patients underwent a second angioplasty procedure and the other received a second stem . On follow-up angiography in the patient (with mastocytosis) who presented with transient occlusion on the day of implantation, the scent was found to be occluded . :)o restenosis within the stent was documented . The mean intraluminal diameter within the stent was 2 .77 1 0.5 mm (n = 14) after implantation and 2 .67 0 .5 mm (n = 14) on control follow-up angiography (p = NS) . Figure I show, the coronary angiogram immediately after implantation and 3.5 years later in one of our patients . The follow-up period was event free in 14 (82%) of the 17 patients, and all are in functional class 1 . A stress test was performed in 13 patients I and 2 years after implantation and results were normal in 12 patients . The patient with documented chronic occlusion had a positive stress test result. Thallium scintigraphy was not performed as a routine follow-up procedure .
Discussion
Previous studies (3, 4) have shown the efficacy of coronary stenting for the treatment of coronary artery dissection and occlusion after balloon angioplasty. However, few data are available on the long-term outcome of patients with a scent implanted for treatment of acute occlusion. Recently, Haude et al . (8) reported the first results with the PalmazSchatz stem implanted in patients with acute occlusion after coronary angioplasty. Although immediate results were encouraging, restenosis occurred in 3 (25%) of 12 patients (all with multiple stem implants) and reocclusion occurred in I patient 15%) : Due additional patient underwent coronary artery bypass grafting . Thus, among the 15 patients included in their study, 8 patients (53%) had complete clinical and angiographic follow-up without subsequent cardiac events or restenosis .
We recently reported (7) the long-term follow-up of our first group of patients with the self-expanding scent. Although this group differs slightly from the group of Haude et al. (8) . the combined incidence of restenosis and occlusion is similar . Effectively, the incidence of restenosis and stent occlusion in the patients with complete clinical follow-up is 23% in our institution compared with 33% in the patients studied by Haude et al . (8) . These results may discredit the use of stems in coronary occlusion after angioplasty. However, the data should be compared with the high mortality and morbidity rates of emergency surgery in the setting of acute coronary occlusion, In our patient group, those whose stem was implanted it, the left anterior descending coronary artery bad a significantly worse outcome than that of patients whose stent was implanted in the right coronary artery . In the study by Haude et al . (8) , data do not permit a definite conclusion because only four of their patients had a stent implanted in the right coronary artery .
Thus, we have identified a group of patients in whom acute occlusion developed (B) and necessitated the implantation of a 3 .5-mm diameter self-expanding stem . The result'.: h after implantation was excellent . Three years later (C) . flocN is very good and there is ec resteness.
coronary stent implantation is very effective in the treatment of acute occlusion after angioplasty . The short-and longtern follow-up prognosis is excellent, with a low incidence of complications. The incidence of myocardial infarction was high in our study, but our criteria to diagnosing infarction were severe and bawd on only a shut increase in CK in four patients. Only one f -treat had a change in left ventricular function after stent implantation, which confirmed that the increase was more the result of transient isehemia than of myocardial necrosis . Restenosis within the stem was not observed in our small group, and only one patient, who had not been treated with an antiplatelet agent . experienced reocclusion. Angiographic quantitative analysis confirms the visual estimation because the internal diameter of the coronary lumen decreased very little during almost 3 years of follow-up . This observation confirms the impression that resenosis after a stem procedure, as after conventional GOY ET AL . 1595 SELF-EXPANDING CORONARY STENT angioplasty. occurs during the I st 6 months after the procedure .
We believe that scent implantation is the treatment of choice for right coronary artery occlusion . The reason for the different outcome in patients with a stent in the left , mlitocenshagvniaustimrightCOr0awiyalldy,aaaet4 unclear . but several hypotheses can be advanced. The shearing forces and flow differ in the two vessels . Moreover, in our patients, stems implanted in the right coronary artery were generally larger than stents implanted elsewhere. This view is supported by the fact that stent diameter was 3 or 3.5 mm in those patients who had acute occlusion after placement of a stent in the left anterior descending coronary artery .
Clinical implications, Our results confirm that implantation of the self-expanding coronary stent is effective in the treatment of coronary occlusion after right coronary
